Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Dermatology | Family Medicine
Search Medical Condition
Hair Loss Clinical Trials
A listing of Hair Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (32) clinical trials
Hair Loss Study For Men & Women
An enriched plasma hair re-growth study for the treatment of male and female pattern hair loss. Are you interested in participating in a Hair Loss study to evaluate the thinning of hair using Platelet Rich Plasma for male and females with Androgenetic Alopecia (AGA)? Participants will receive treatment at no ...
Hair Loss?
A Clinical Trial seeking patients for a research study for the treatment of Hair Disease.
A Randomized, Double-blind, Vehicle-controlled Single Center Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ATI-50002 Topical Solution Administered Twice-Daily for 28 Days in Adult Subjects with Alopecia Universalis and Alopecia Totalis
The objective of this study is to assess the safety tolerability, pharmacokinetics and pharmacodynamics of ATI-50002 Topical Solution, 0.46% compared to vehicle in subjects with alopecia universalis (AU) and alopecia totalis (AT) over the course of one month of continuous daily use.
Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control. The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units. Patients will be followed for a nine months period of ...
Efficacy Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
The aim of this trial is to compare the degree of efficacy, safety and tolerability of CG 428 cutaneous solution versus placebo on prevention of chemotherapy induced alopecia (CIA) in female patients with metastatic cancer treated with selected regimens inducing alopecia.
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
SAD part: A total of 3 weeks dosing, the two lowest concentrations in week 1, dose 3 at week 2 and finally dose 4 at week 3. MD part: In total 12 weeks of dosing where group A will be dosed twice weekly and group B three times weekly Each ...
Hairstetics Hair Implant Device Safety and Efficacy
This is a prospective, single-arm, multi-center, international, open-label, non-randomized, clinical study. The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair implant device in subjects affected with hair loss.
PAI-1 Expression in Non-scarring Hair Loss
This study will compare the levels of PAI-1 expression in subjects with different forms of non-scarring hair loss and in these subjects vs normal age-matched controls. Hair loss subjects will have their Northwestern Memorial Hospital and Northwestern Medical Faculty Foundation medical records reviewed to ensure they meet inclusion and exclusion ...
TREg Activation in the Treatment of the PELADE (Alopecia Areata)
In a prospective pilot study the investigators showed that low doses of IL2 could be beneficial for severe AA inducing a long lasting regrowth in 4 out of the 5 patients treated. The objective of this study is to compare the long term efficacy of low doses of IL2 versus ...
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can contribute to the distress and social isolation of patients with advanced cancer. In this study a topical gel will be applied directly to the scalp during each dose of radiotherapy. The goal is to ...
